These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28242275)

  • 21. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
    McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
    ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boromycin Has Potent Anti-
    Abenoja J; Cotto-Rosario A; O'Connor R
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468470
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for the shikimate pathway in apicomplexan parasites.
    Roberts F; Roberts CW; Johnson JJ; Kyle DE; Krell T; Coggins JR; Coombs GH; Milhous WK; Tzipori S; Ferguson DJ; Chakrabarti D; McLeod R
    Nature; 1998 Jun; 393(6687):801-5. PubMed ID: 9655396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
    Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
    ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
    Andrade RM; Chaparro JD; Capparelli E; Reed SL
    PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.
    Darkin-Rattray SJ; Gurnett AM; Myers RW; Dulski PM; Crumley TM; Allocco JJ; Cannova C; Meinke PT; Colletti SL; Bednarek MA; Singh SB; Goetz MA; Dombrowski AW; Polishook JD; Schmatz DM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13143-7. PubMed ID: 8917558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of a novel calcium-activated apyrase from Cryptosporidium parasites and its potential role in pathogenesis.
    Manque PA; Woehlbier U; Lara AM; Tenjo F; Alves JM; Buck GA
    PLoS One; 2012; 7(2):e31030. PubMed ID: 22363541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs in development for toxoplasmosis: advances, challenges, and current status.
    Alday PH; Doggett JS
    Drug Des Devel Ther; 2017; 11():273-293. PubMed ID: 28182168
    [No Abstract]   [Full Text] [Related]  

  • 31. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
    Deng Y; Wu T; Zhai SQ; Li CH
    Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apicomplexan infections in the gut.
    Wilhelm CL; Yarovinsky F
    Parasite Immunol; 2014 Sep; 36(9):409-20. PubMed ID: 25201405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of
    Alday PH; Nilsen A; Doggett JS
    Expert Opin Drug Discov; 2022 Sep; 17(9):997-1011. PubMed ID: 35772172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.
    Nare B; Allocco JJ; Liberator PA; Donald RG
    Antimicrob Agents Chemother; 2002 Feb; 46(2):300-7. PubMed ID: 11796334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of persistent Cryptosporidium spp. infestation in a child with acute myeloid leukemia.
    Pérez-Heras Í; García-Palomo M; Herrera-López M; González-Granado LI; Domínguez-Pinilla N
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28470. PubMed ID: 32776427
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.
    Rocha-Roa C; Molina D; Cardona N
    Front Cell Infect Microbiol; 2018; 8():360. PubMed ID: 30386743
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
    Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the activity of Obioactin with acetylspiramycin on mice infected with Toxoplasma gondii.
    Suzuki N; Espinas FM; Sakurai H; Saito A; Sasaki H; Kato G; Manba K; Taniguchi K; Mochizuki K; Osaki H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):367-80. PubMed ID: 6730783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.